12:58 PM
Jalal HB
The first once-a-day anti-clotting drug for patients with an irregular heartbeat has been given the green light for use on the NHS.
Rivaroxaban works as well as warfarin, a treatment based on rat poison which has been used since the 1950s, but with fewer side effects.
Hundreds of thousands of patients with atrial fibrillation (AF) could be eligible, which may prevent 5,000 strokes a year.
Read more: Mail Online
Posted in: 
0 comments:
Post a Comment